Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of rifaximin and pharmaceutical formulations containing it in the treatment of gastric dyspepsia caused by helicobacter pylori

Use of rifaximin and pharmaceutical formulations containing it in the treatment of gastric dyspepsia caused by helicobacter pylori

US Patent 5352679 · Granted Oct 4, 1994

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bifidobacteria and preparations containing them2005
Pharmaceutical compositions containing calcitonin in a spray dosing feeder for i2000
Use of rifaximin and of pharmaceutical compositions containing it in the treatme1999
Programmed release tablets containing naproxen1996
Pharmaceutical compositions containing orally absorbable glycosamimoglycans1993
Galenic formulations with programmed release1991
Galenic formulations with programmed release containing naproxen1989